Items where Author is "Martin, K. R."
Rabiolo, A. 
ORCID: 0000-0002-7772-5929, Montesano, G. ORCID: 0000-0002-9148-2804, Crabb, D. P. ORCID: 0000-0001-8754-3902 , Garway-Heath, D. F., Bunce, C., Lascaratos, G., Amalfitano, F., Anand, N., Azuara-Blanco, A., Bourne, R. R., Broadway, D. C., Cunliffe, I. A., Diamond, J. P., Fraser, S. G., Ho, T. A., Martin, K. R., McNaught, A. I., Negi, A., Patel, K., Russell, R. A., Shah, A., Spry, P. G., Suzuki, K., White, E. T., Wormald, R. P., Xing, W. & Zeyen, T. G. (2024).
Relationship between Intraocular Pressure Fluctuation and Visual Field Progression Rates in the United Kingdom Glaucoma Treatment Study.
Ophthalmology, 131(8),
pp. 302-913.
doi: 10.1016/j.ophtha.2024.02.008
Jones, L., Garway-Heath, D. F., Azuara-Blanco, A. , Crabb, D. P. ORCID: 0000-0001-8754-3902, Bunce, C., Lascaratos, G., Amalfitano, F., Anand, N., Bourne, R., Broadway, D. C., Cunliffe, I. A., Diamond, J. P., Fraser, S. G., Ho, T. A., Martin, K. R., McNaught, A., Negi, A., Patel, K., Russell, R. A., Shah, A., Spry, P. G., Suzuki, K., White, E.T., Wormald, R., Xing, W. & Zeyen, T. G. (2018).
Are Patient Self-Reported Outcome Measures Sensitive Enough to Be Used as End Points in Clinical Trials?: Evidence from the United Kingdom Glaucoma Treatment Study.
Ophthalmology, 126(5),
pp. 682-689.
doi: 10.1016/j.ophtha.2018.09.034
Garway-Heath, D. F., Crabb, D. P., Bunce, C. V. , Lascaratos, G., Amalfitano, F., Anand, N., Azuara-Blanco, A., Bourne, R., Broadway, D. C., Cunliffe, I. A., Diamond, J. P., Fraser, S. G., Ho, T. A., Martin, K. R., McNaught, A., Negi, A., Patel, K., Russell, R. A., Shah, A., Spry, P. G., Suzuki, K., White, E.T., Wormald, R., Xing, W. & Zeyen, T. G. (2015). Latanoprost for open-angle glaucoma (UKGTS): A randomised, multicentre, placebo-controlled trial. The Lancet, 385(9975), pp. 1295-1304. doi: 10.1016/s0140-6736(14)62111-5
Martin, K. R., Hirson, A., Herman, R. , Thomas, J. & Pring, T. (2007). The efficacy of speech intervention using electopalatography with an 18 year old deaf client: A single case study. Advances in Speech-Language Pathology, 9(1), pp. 46-56. doi: 10.1080/14417040601120912